Back
MiMedx Group Vs. Protalix BioTherapeutics Industry Stock Comparison
Buy
84
MDXG
MiMedx Group
Last Price:
9.28
Seasonality Move:
15.95%
Buy
71
PLX
Protalix BioTherapeutics
Last Price:
1.39
Seasonality Move:
78.33%
Buy
84
MiMedx Group (MDXG)
is a Buy
Is MiMedx Group a Buy, Sell or Hold?
- The current MiMedx Group [MDXG] share price is $9.28. The Score for MDXG is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- MDXG is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
71
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.40. The Score for PLX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDXG Stock Price Chart
What is MiMedx Group's stock price today?
-
The MiMedx Group share price today is $9.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDXG is experiencing slight buying pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDXG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.69 | Buy |
Relative Strength Index (14 RSI): | 86.71 | Buy |
Chaikin Money Flow: | 540571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.59 - 7.75) | Buy |
Bollinger Bands (100): | (5.84 - 7.3) | Buy |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 67.1 | Buy |
Chaikin Money Flow: | 245801 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.06 - 1.28) | Buy |
Bollinger Bands (100): | (0.98 - 1.18) | Buy |
MDXG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.95 | Buy |
20-day SMA: | 6.89 | Buy |
50-day SMA: | 6.31 | Buy |
200-day SMA: | 7 | Buy |
8-day EMA: | 8.08 | Buy |
20-day EMA: | 7.24 | Buy |
50-day EMA: | 6.68 | Buy |
200-day EMA: | 6.78 | Buy |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Buy |
20-day SMA: | 1.19 | Buy |
50-day SMA: | 1.11 | Buy |
200-day SMA: | 1.18 | Buy |
8-day EMA: | 1.3 | Buy |
20-day EMA: | 1.22 | Buy |
50-day EMA: | 1.14 | Buy |
200-day EMA: | 1.21 | Buy |
MiMedx Group Earnings Growth & MDXG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.03 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiMedx Group Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |